PSA on HCV: Provides a 2-minute overview of the importance of HCV treatment and screening for women age 15-44.Provides an overview of new direct-acting antiviral (DAA) therapies that cure chronic HCV infection. (July 2017)
NYSDOH HCV Dear Colleague Letter Regarding Women of Childbearing Age. (February 2017)
This letter informs health care providers of the increases in HCV among women of child bearing age (15-44 years). Multiple free resources are provided. Recent data shows a 22% increase in HCV rates among women of child bearing age. New and more effective HCV treatments and screening among women of child bearing age can act as a prevention intervention. Women identified with HCV can be treated before becoming pregnant. HCV testing is recommended for persons with a history of injection drug use and others at risk.
Page updated 8/9/17